Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04356326 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy

Study acronym: CHASAP
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Feb 2026 to Feb 28, 2029v13
  2. Re-verified, no change to tracked fieldsv12
  3. Study sites: 18 to 20
    • Eligibility criteria expanded, about 8 words
    v11
  4. Primary completion date: Sep 2024 to Feb 2026
    • Study sites: 17 to 18
    • Study completion date: Oct 2028 to Feb 2030
    v10
  5. Study sites: 16 to 17
    • Eligibility criteria revised
    • Secondary endpoints: 17 to 18
    • Study description revised
    v9
Show 7 earlier versionsHide 7 earlier versions
  1. Secondary endpoints: details revised at 1 of 17 entriesv8
  2. Study sites: 15 to 16
    • Secondary endpoints: 16 to 17
    v7
  3. Study description expanded, about 1 wordv6
  4. Secondary endpoints: details revised at 1 of 16 entries
    • Study description expanded, about 148 words
    v5
  5. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jan 2021 to Feb 15, 2021
    • Site details revised at 15 of 15 sites
    v4
  6. Study sites: 16 to 15
    • Study completion date: Oct 2024 to Oct 2028
    • Eligibility criteria expanded, about 38 words
    • Secondary endpoints: 14 to 16
    v3
  7. Secondary endpoints: details revised at 1 of 14 entries
    • Study description expanded, about 7 words
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A randomized clinical trial to assess the efficiency of acetylsalicylic acid (aspirin) 150 mg/day started before 20 weeks of gestation in the prevention on maternal and fœtal complications in pregnant women with chronic hypertension.
Trial Details
NCT Number NCT04356326
Lead Sponsor Centre Hospitalier Intercommunal Creteil
Conditions
(from sponsor)		 Chronic Hypertension Complicating Pregnancy, Pre-Eclampsia, Intrauterine Growth Restriction, Aspirin, Perinatal Death, Placental Abruption
Related terms Abruptio Placentae, Fetal Growth Retardation, Perinatal Death, Pre-Eclampsia
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov